These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7812951)

  • 21. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.
    Watson AJ; Merritt AJ; Jones LS; Askew JN; Anderson E; Becciolini A; Balzi M; Potten CS; Hickman JA
    Br J Cancer; 1996 Apr; 73(8):889-95. PubMed ID: 8611422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCL-2 expression in human colorectal adenomas and carcinomas.
    Hague A; Moorghen M; Hicks D; Chapman M; Paraskeva C
    Oncogene; 1994 Nov; 9(11):3367-70. PubMed ID: 7936663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
    Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 expression in colorectal adenomas.
    Kaklamanis L; Gatter KC; Mortensen N; Baigrie RJ; Heryet A; Lane DP; Harris AL
    Am J Pathol; 1993 Jan; 142(1):87-93. PubMed ID: 7678722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis.
    Mikami T; Yanagisawa N; Baba H; Koike M; Okayasu I
    Cancer; 1999 Jan; 85(2):318-25. PubMed ID: 10023698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis.
    Ward RL; Todd AV; Santiago F; O'Connor T; Hawkins NJ
    Cancer; 1997 Mar; 79(6):1106-13. PubMed ID: 9070487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of apoptosis-related protein in epithelial dysplasia and squamous cell carcinoma].
    Guan W; Yu S; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):65-8. PubMed ID: 11955367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
    Kikuchi Y; Dinjens WN; Bosman FT
    Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
    Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
    Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms.
    Kondo E; Miyake T; Shibata M; Kimura T; Iwagaki H; Nakamura S; Tanaka T; Ohara N; Ichimura K; Oka T; Yanai H; Shibasaki F; Yoshino T
    Clin Cancer Res; 2005 Oct; 11(20):7255-63. PubMed ID: 16243795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
    Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
    Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma.
    Lee WY; Jin YT; Tzeng CC
    Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas.
    Bosari S; Moneghini L; Graziani D; Lee AK; Murray JJ; Coggi G; Viale G
    Hum Pathol; 1995 May; 26(5):534-40. PubMed ID: 7750937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
    Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
    J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
    Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
    Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
    Han HS; Park YM; Hwang TS
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
    Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
    Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonic mucin-carbohydrate components in colorectal tumors and their possible relationship to MUC2, p53 and DCC immunoreactivities.
    Hara A; Saegusa M; Mitomi H; Kurihara M; Ishihara K; Hotta K; Okayasu I
    Pathol Res Pract; 2000; 196(3):159-66. PubMed ID: 10729920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.